Ocular Excipient Market
Ocular Excipient Market Study by Diluents, Glidants, Disintegrants, Binders, Lubricants, Tablet Coatings & Films, and Coloring Agents for Pharmaceuticals and Other Companies From 2024 to 2034
Analysis of Ocular Excipient Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Ocular Excipient Market Outlook (2024 to 2034)
Revenue from the global ocular excipient market is analyzed to reach US$ 900 million in 2024 and touch a value of US$ 2.13 billion by the end of 2034. This latest research study by skilled analysts at Fact.MR states that worldwide demand is projected to rise at a CAGR of 9% between 2024 and 2034.
The market for ocular excipients is significantly influenced by the rising prevalence of eye conditions, such as age-related macular degeneration (AMD), glaucoma, cataracts, and dry eye syndrome. This increasing load is caused by several factors, including aging populations, extended screen time, environmental stressors, and others, all of which call for efficient ocular treatments.
Drug retention, bioavailability, and controlled release are enhanced by advancements in ocular drug delivery technologies, including hydrogels, nano-formulations, and microspheres. Excipients that guarantee stability, solubility, and compatibility with ocular tissues are crucial to these developments.
The requirement for non-irritating and biocompatible excipients to improve the efficacy and safety of ocular formulations is growing. Because of their ability to moisturize, stabilize, and produce films, excipients, such as hyaluronic acid, carboxymethyl cellulose, and polyethylene glycols (PEGs) are widely included in ophthalmic products.
North America is estimated to hold 36.9% of the worldwide market share in 2024 because of the high prevalence of eye illnesses, substantial R&D expenditures, and well-established healthcare infrastructure. The need for advanced and new ophthalmic medication formulations is driven by the aging population as well as the rise in glaucoma and dry eye syndrome patients.
Based on product type, the demand for diluents is projected to reach US$ 386.4 million in 2024 due to their vital function in improving the stability, solubility, and bioavailability of ophthalmic medications. By lowering concentration variability and enhancing formulation consistency, diluents are crucial for precise drug administration, particularly in liquid and semi-solid treatments, such as ointments and eye drops.
| Report Attribute | Detail |
|---|---|
| Ocular Excipient Market Size (2024E) | US$ 900 Million |
| Forecasted Market Value (2034F) | US$ 2.13 Billion |
| Global Market Growth Rate (2024 to 2034) | 9% CAGR |
| North America Market Share (2024E) | 36.9% |
| East Asia Market Value (2024E) | US$ 155.16 Million |
| South Asia & Pacific Market Growth Rate (2024 to 2034) | 12.2% CAGR |
| Diluents Segment Value (2034F) | US$ 990.9 Million |
| Organic Compounds Segment Value (2034F) | US$ 1.01 Billion |
| Key Companies Profiled | Anton Paar; BASF; Beneo; Evonik; EXCi PACT; Fuji Chemical Industries USA, Inc.; InVitria; Innophos; JRS Pharma; IOI Oleochemical; Millipore Sigma; Mallinckrodt Pharmaceuticals; Pfanstiehl; Perkin Elmer; Natoli; DFE Pharma |
Smoothening of FDA approval processes has been crucial for this market as novel excipients with improved functionalities are easily approved and used for better formulation without being stuck in the legal web.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
What is driving the demand for the Ocular Excipients Market?
Excipients are an important part of the drug development process and ensure that the formulation remains stable throughout the development process as well as when it is administered. It is basically any other component of the drug outside the medicinal component as it acts as a vehicle or a carrier for the medicinal product.
This way stability to the formulation is provided. The wrong selection of excipients leads to complications, such as intoxication of the patients. In ocular drugs, they play an important role in maintaining the tonicity, pH, stability, viscosity, and sterility of the formulation.
Novel systems for drug delivery are invented on a very large scale and this is driving the excipients market, as certain advanced forms are required to put certain specific properties into the formulation. In this case, a single excipient is required to perform several functionalities to make the formulation versatile and novel. This factor will ultimately improve the overall performance of the drug, which will finally lead to financial gains in the market.
Another major driver that emerges is that of new excipients, which will change the landscape of disease treatment the characteristic of this component is to prove effective in multiple ways in a formulation of the drug where they play diverse roles in ensuring the effectiveness of the drug which their earlier counterparts didn’t.
The pharmaceutical landscape is changing very rapidly and due to the emergence of new diseases, the research has gained pace. This in turn demands the development of improved drugs; for which some of the previously used excipients might not be suitable. This has boosted the manufacturers in searching for new excipients, which are more suitable with their versatile capabilities.
The main issue with ocular drug delivery is its very poor bioavailability due to the rapid washout of the drug. This results in low permeation through the membranes.
A 15 April 2021, study published in the International Journal of Pharmaceutics analysed muco-adhesiveness and permeation capability of a new excipient known as thiolated cyclodextrins. Improvement in permeation in the conjunctiva, sclera, as well as cornea, was seen. This also unlatches a new pathway into using thiolated cyclodextrins as an excipient in many more drug formulations in the future.
Newly Emerged Excipients with an Application in the Ocular Market
Ocular drug delivery has been mostly limited to injections and topical applications. The most widely used topical application has proven to be a convenient method despite it failing to maintain an effective level of concentration of the drug at the target site for the ideal time period.
The 2021 review article from MDPI has collectively put up the latest advances in the excipients market, which have the potential in improving the bioavailability of ocular drugs. Chitosan, hyaluronic acid, poloxamers, and gelatin are a few noteworthy that have displayed a promising potential in limiting the limitations presented by previous ocular delivery systems.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
The US and Canada Excipient Market
The healthcare system of the U.S. is well known for its advanced infrastructure and expenditure. Various regulatory rules and insurance policies are adopted to control the healthcare regime of the country. The US doesn’t have a specific regulation when it comes to pharmaceutical excipients as long as they fit the mechanisms of approval set by the US FDA. This is sure to boost the acceptance of novel excipients in the US and make it the most lucrative market.
Europe Ocular Excipients Market
Europe is the second major market in this field as efforts are made by the International Pharmaceutical Excipients Commission about getting the necessary approvals and recognitions from the European Union with respect to the evolving excipient market.
At the IPEC Europe Excipient Forum of 2018, it was updated that excipients, which have improved functionalities in comparison to the regular blends were not clearly defined in the European Union, despite them being marketed as one for many years. It was then decided that a draft is to be sent to the EU Commission with specific quality control measures required for these Co-processed excipients or CPEs for a review.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Who are the key manufacturing supplying companies in the Ocular Excipients market?
Key manufacturers and suppliers:
- Anton Paar
- BASF
- Beneo
- Evonik
- EXCi PACT
- Fuji Chemical Industries USA, Inc.
- InVitria
- Innophos
- JRS Pharma
- IOI Oleochemical
- Millipore Sigma
- Mallinckrodt Pharmaceuticals
- Pfanstiehl
- Perkin Elmer
- Natoli
- DFE Pharma
Ocular Excipient Market Report Highlights:
- Detailed overview of the parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current, and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint
Segmentation of Ocular Excipient Market Research
-
By Product Type :
- Diluents
- Glidants
- Disintegrants
- Binders
- Lubricants
- Tablet Coatings & Films
- Coloring Agents
-
By Source :
- Organic Compounds
- Inorganic Compounds
- Natural Polymers
- Synthetic Polymers
- Silica Compounds
- Water-soluble Compounds
-
By End User :
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Contract Manufacturing Organizations (CMOs)
- Contract Development & Manufacturing Organization (CDMO)
-
By Region :
- North America
- Western Europe
- Eastern Europe
- Latin America
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis and Forecast
- 6.1. Product Type
- 6.2. Source
- 6.3. End User
- 7. Global Market Analysis and Forecast, By Product Type
- 7.1. Dilutents
- 7.2. Glidants
- 7.3. Disintegrants
- 7.4. Binders
- 7.5. Lubricants
- 7.6. Tablet coatings and films
- 7.7. Colouring agents
- 8. Global Market Analysis and Forecast, By Source
- 8.1. Organic Compounds
- 8.2. Inorganic Compounds
- 8.3. Natural Polymers
- 8.4. Synthetic Polymers
- 8.5. Silica Compounds
- 8.6. Water-soluble Compounds
- 9. Global Market Analysis and Forecast, By End User
- 9.1. Pharmaceutical Companies
- 9.2. Biopharmaceutical Companies
- 9.3. Contract Manufacturing Organizations (CMOs)
- 9.4. Contract Development & Manufacturing Organization (CDMO)
- 10. Global Market Analysis and Forecast, By Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Western Europe
- 10.4. Eastern Europe
- 10.5. East Asia
- 10.6. South Asia & Pacific
- 10.7. MEA
- 11. North America Sales Analysis and Forecast, by Key Segments and Countries
- 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries
- 13. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
- 14. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
- 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries
- 16. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries
- 17. MEA Sales Analysis and Forecast, by Key Segments and Countries
- 18. Sales Forecast by Product Type, Source, and End User for 30 Countries
- 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 20. Company Profile
- 20.1. Anton Paar
- 20.2. BASF
- 20.3. Beneo
- 20.4. Evonik
- 20.5. EXCi PACT
- 20.6. Fuji Chemical Industries USA, Inc.
- 20.7. InVitria
- 20.8. Innophos
- 20.9. JRS Pharma
- 20.10. IOI Oleochemical
- 20.11. Millipore Sigma
- 20.12. Mallinckrodt Pharmaceuticals
- 20.13. Pfanstiehl
- 20.14. Perkin Elmer
- 20.15. Natoli
- 20.16. DFE Pharma
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Product Type
Table 3: Global Market US$ Mn Forecast by Source
Table 4: Global Market US$ Mn Forecast by End User
Table 5: North America Market US$ Mn Forecast by Country
Table 6: North America Market US$ Mn Forecast by Product Type
Table 7: North America Market US$ Mn Forecast by Source
Table 8: North America Market US$ Mn Forecast by End User
Table 9: Latin America Market US$ Mn Forecast by Country
Table 10: Latin America Market US$ Mn Forecast by Product Type
Table 11: Latin America Market US$ Mn Forecast by Source
Table 12: Latin America Market US$ Mn Forecast by End User
Table 13: Western Europe Market US$ Mn Forecast by Country
Table 14: Western Europe Market US$ Mn Forecast by Product Type
Table 15: Western Europe Market US$ Mn Forecast by Source
Table 16: Western Europe Market US$ Mn Forecast by End User
Table 17: Eastern Europe Market US$ Mn Forecast by Country
Table 18: Eastern Europe Market US$ Mn Forecast by Product Type
Table 19: Eastern Europe Market US$ Mn Forecast by Source
Table 20: Eastern Europe Market US$ Mn Forecast by End User
Table 21: East Asia Market US$ Mn Forecast by Country
Table 22: East Asia Market US$ Mn Forecast by Product Type
Table 23: East Asia Market US$ Mn Forecast by Source
Table 24: East Asia Market US$ Mn Forecast by End User
Table 25: South Asia & Pacific Market US$ Mn Forecast by Country
Table 26: South Asia & Pacific Market US$ Mn Forecast by Product Type
Table 27: South Asia & Pacific Market US$ Mn Forecast by Source
Table 28: South Asia & Pacific Market US$ Mn Forecast by End User
Table 29: MEA Market US$ Mn Forecast by Country
Table 30: MEA Market US$ Mn Forecast by Product Type
Table 31: MEA Market US$ Mn Forecast by Source
Table 32: MEA Market US$ Mn Forecast by End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Source
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Source
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 10: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Source
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 14: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Source
Figure 15: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 17: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 18: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Source
Figure 19: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 20: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 21: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 22: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Source
Figure 23: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 24: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 25: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 26: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Source
Figure 27: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 28: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 29: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 30: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Source
Figure 31: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 32: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How much is the ocular excipients market analyzed to register during the forecast period?
The ocular excipients market is projected to record a CAGR of 9% during the forecast period.
Why ocular excipients market have high growth potential?
The market is expanding due to the rise in drug development processes and changes in the landscape of disease treatment.
Where will manufacturers find the most opportunities in the ocular excipients market?
The manufacturers are finding remunerative opportunities in the United States and Canada in the North American region.
Ocular Excipient Market